# A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

> **NCT05780294** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 132 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Leucogen
- Chemotherapy
- Myelosuppression

## Interventions

- **DRUG:** 5-fu
- **DRUG:** Lobaplatin
- **DRUG:** Placebo
- **DRUG:** leucogen

## Key facts

- **NCT ID:** NCT05780294
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2029-12-01
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2023-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05780294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05780294, "A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05780294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*